Medical / Pharmaceuticals News and Press Releases

Medical / Pharmaceuticals

Releases published in the last 30 days.

Page 1 of 2

Sanofi and Regeneron’s Dupixent approved in the US as the first biologic medicine for young children with uncontrolled chronic spontaneous urticaria: 4/23/2026 11:08:24 AM; • Approval for children aged two to 11 years with CSU who remain symptomatic despite H1 antihistamine treatment based primarily on data from the LIBERTY-CUPID clinical study program • CSU is a chronic skin disease that causes itch and hives that can be debilitating for young children, especially for those whose disease remains uncontrolled • CSU marks the fifth disease …
How do patients’ relatives and friends view the benefits and harms of electroconvulsive therapy?: 4/23/2026 10:07:34 AM; Electroconvulsive therapy (ECT), which involves passing electricity through the brain under general anesthesia to cause a seizure, usually between six and twelve times, is used to varying degrees around the world for patients with depression and other mental conditions.
AMA urges Congress to strengthen safeguards for AI chatbots: 4/22/2026 12:15:34 PM; The American Medical Association (AMA) today urged federal lawmakers to put stronger safeguards in place as the use of augmented intelligence (AI) chatbots in mental health care continues to grow.
Sanofi’s Tzield approved in the US to delay the onset of stage 3 type 1 diabetes in young children: 4/22/2026 11:18:17 AM; • Expanded approval includes children aged one year and above with stage 2 T1D to delay the onset of stage 3 • Tzield is the first disease-modifying therapy for children aged one year and above diagnosed with stage 2 T1D The US Food and Drug Administration (FDA) has approved the supplemental biologic license application for Tzield (teplizumab-mzwv), expanding the …
AMA: Physician burnout rates are falling, specialty gaps remain: 4/20/2026 11:06:30 AM; New data from the American Medical Association (AMA) show physician burnout continuing to decline nationwide, but significant differences across medical specialties underscore the need for more targeted solutions within health systems.
Telehealth and Medicine Today Achieves Q2 SCImago Ranking Advancing Its Global Research Presence: 4/20/2026 8:00:00 AM; Telehealth and Medicine Today (THMT), the peer-reviewed open access journal published by Partners in Digital Health, has achieved a Q2 quartile ranking in SCImago Journal Rank 2025—placing it in the top half of journals globally and reflecting the journal’s growing interdisciplinary reach and the quality of research it has published since its founding.
Novel Research Reveals the Active Role that Skin Cells Play in Rabies Infection: 4/17/2026 12:21:02 PM; While it was previously thought that keratinocytes (skin cells) were only passive conductors that allow the rabies virus to pass through, novel research reveals that these cells play a much more active role.
Osteoboost Secures $8M to Expand Access to its FDA-Cleared Prescription Wearable for Bone Health: 4/15/2026 12:00:00 PM; Osteoboost Health, Inc., today announced it has closed an $8 million financing round to scale manufacturing, expand clinical research, and broaden the commercial reach of the company’s FDA-cleared medical device for low bone density.
UK start-ups to power a new wave of quantum innovation: 4/15/2026 11:02:24 AM; The start-ups have joined the DeepTech Catalyst Quantum incubator programme (DTC Quantum), where they will use quantum technologies to develop and commercialise new products designed to deliver practical, real-world benefits.
FDA Issues Draft Guidance on Genome Editing Safety Standards to Advance Gene Therapy Development: 4/15/2026 10:11:56 AM; The U.S. Food and Drug Administration issued a draft guidance for sponsors seeking approval of human gene therapy products involving genome editing technologies.
AMA launches “Health vs. Hype” podcast series with iHeartMedia: 4/15/2026 10:05:05 AM; The American Medical Association (AMA), in collaboration with iHeartMedia’s Ruby studio, today announced the launch of its new podcast series, “Health vs.
Osteoboost and Midi Health to Host Free Webinar on HRT and Bone Density for Women in Menopause: 4/14/2026 12:03:23 PM; Osteoboost Health, Inc. and Midi Health will co-host a free public webinar, HRT and the New Science of Strong Bones, on Thursday, April 16, 2026, at 2 p.m.
Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous urticaria: 4/13/2026 8:27:56 PM; The European Commission has approved Dupixent (dupilumab) for the treatment of moderate-to-severe chronic spontaneous urticaria (CSU) in children aged two to 11 years with inadequate response to histamine-1 antihistamines (H1AH) and who are naïve to anti-immunoglobulin E (IgE) therapy for CSU.
The Brain’s Emotional Hub Is Linked to Alcohol Use Differently in Young Men and Women: 4/13/2026 12:39:16 PM; New research shows that the threat-response in the brain’s amygdala (which processes emotions) is linked to different patterns of drinking by sex. In young males, heightened amygdala reactivity was linked to increased depressive symptoms, which in turn predicted heavier alcohol consumption.
Ardian signs an agreement to acquire a stake in IVB Wellness Lab, a fast‑growing and innovative supplements brand in Spain: 4/13/2026 4:24:41 AM; IVB Wellness Lab (“IVB”), a leading Spanish company in the research, development and distribution of science‑backed dietary supplements, welcomes Ardian, a global private investment firm, as a minority shareholder.
Food Literacy Program Helps Rural, Uninsured Patients With Diabetes Build Healthy Eating Skills: 4/11/2026 8:58:11 AM; A recent study in the Journal of Nutrition Education and Behavior (JNEB), published by Elsevier, examined the impact of a Food is Medicine (FIM) and food literacy education program on rural, uninsured adults with type 2 diabetes.
First-ever WHO Forum unites 800+ Collaborating Centres for stronger scientific collaboration: 4/10/2026 9:04:55 AM; The World Health Organization (WHO) has convened the historic first Global Forum of Collaborating Centres—one of the world’s largest and most diverse public health networks—bringing together representatives from over 800 institutions designated as WHO Collaborating Centres (CCs) across more than 80 countries.
A New Book Encourages Patients to Take Control of Their Healthcare: 4/8/2026 2:54:37 PM; For many people, healthcare has become increasingly complicated. Long wait times, rising costs, and confusing insurance requirements can leave patients feeling powerless at the very moment they need clarity the most.
Johnson & Johnson Advances Pulsed Field Ablation Portfolio with the Launch of VARIPULSE Pro in Europe: 4/8/2026 12:48:40 PM; Johnson & Johnson announced the launch of VARIPULSE Pro in Europe following CE Mark approval, further advancing its pulsed field ablation (PFA) portfolio.
Mila’s AI drives world’s largest study on psychedelics: 4/8/2026 4:56:49 AM; Psychedelics research is booming, with many research labs seeking cheaper, more effective alternative drug treatments to mental health conditions like depression and schizophrenia.